A recent Pew Research survey shows a significant decline in President Trump's approval ratings, with only 38% of Americans supportive of his performance. This article delves into the survey's findings and public sentiment regarding Trump's policies.
Israel is set to approve the contentious E1 settlement plan for over 3,400 homes, a move denounced by the international community as a threat to the viability of a Palestinian state. The decision could escalate tensions in the region.
The Trump administration's decision to allow Nvidia to export a scaled-down AI chip to China raises serious concerns about U.S. technology supremacy. Critics warn that this could enable China to leapfrog America in AI capabilities.
Dr. Vinay Prasad is back at the FDA's Center for Biologics Evaluation and Research, raising eyebrows after being ousted amid political turmoil and criticism. His return ignites debates about drug approvals and public health leadership under the Trump administration.
In a groundbreaking move, the Alzheimer’s Association recommends blood tests for diagnosing cognitive impairment, potentially increasing access to treatment. This could revolutionize how Alzheimer's is diagnosed, especially in rural areas.
In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.
The EU has recommended lenacapavir, an injectable drug for HIV prevention, which could drastically reduce transmission rates. With nearly 100% effectiveness, it promises a new era in combating HIV.
The European Medicines Agency has recommended the approval of lenacapavir, a twice-yearly injectable drug that could revolutionize HIV prevention and significantly reduce transmission rates globally.
Paramount Global is set to finalize its $8bn merger with Skydance Media, marking a pivotal shift in the entertainment industry under the Trump administration's influence. The merger's approval has raised eyebrows amidst political tensions and a recent lawsuit settlement with Trump.
The FCC has greenlit the $8 billion merger between CBS's parent company Paramount and Skydance Media, amidst accusations of political influence and promises of reform in news coverage.
